The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -0.99 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -3.05 — no flag raisedOK
- Earnings quality 76/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as STANDARD BIOTOOLS INC. reports it. History and quarterly detail are in the app.
- Product$61.7M
- Consumables$36.2M
- Instruments$25.4M
- Services And Other Revenue$23.7M
- Service And Other Revenue$23.7M
Leadership changes
From STANDARD BIOTOOLS INC.'s own filings, the day they're filed.
- Jeremy Davis · Chief Commercial Officer · departureeff. 2025-02-01
- Alex Kim · Chief Financial Officer · appointmenteff. 2024-11-11
- Jeffrey Black · Chief Financial Officer · departureeff. 2024-08-31
Latest filings
- 8-K · Company announcement2026-06-18
- 8-K · Company announcement2026-06-08
- 8-K · Company announcement2026-06-05
- 8-K · Company announcement2026-06-03
- 8-K · Company announcement2026-05-28
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about STANDARD BIOTOOLS INC., every answer cited🔒
- The Intelligence Brief — added when STANDARD BIOTOOLS INC.'s brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.